Home
Conditions
Proteostasis Deficiencies

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,351 public trials 352 recruiting studies

Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Not Yet Recruiting

Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA)

NCT07099066

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis

NCT07093268

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Sunshine Coast University Hospital Birtinya, Queensland, Australia

Flinders Medical Centre Bedford Park, South Australia, Australia

View Trial Details

Not Yet Recruiting

A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT07082192

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study on the Safety and Efficacy of RAG-21 in the Treatment of Amyotrophic Lateral Sclerosis Patients With FUS Gene Mutations

NCT07080801

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Extended Study of RAG-17 in the Treatment of Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation

NCT07077668

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis

NCT07055724

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases

NCT06607900

Conditions: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Autonomic Nervous System Diseases, +25 more
Locations: Xuanwu Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association With Clinical Phenotypes

NCT06771414

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Systems Biology of Amyotrophic Lateral Sclerosis (ALS)

NCT07007390

Conditions: ALS, ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

NCT06993142

Conditions: Basal Ganglia Diseases, Behavior, Brain Diseases, +21 more
Locations: University of Rochester Center for Health and Technology (CHeT) Rochester, New York, United States

Radboud University Medical Center Nijmegen, Gelderland, Netherlands

View Trial Details

Proteostasis Deficiencies

Proteostasis Deficiencies trial results

Related conditions